Clinical trial
The Safety and Effectiveness of Clarithromycin in the Prevention of…
NCT00002336 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00002336 |
|---|---|
| Title | The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients |
| Official title | A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients With CD4 Counts <= 100 Cells/mm3 |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Mycobacterium Avium-intracellular Infection, HIV Infections |
| Intervention type | Drug |
| Interventions | Clarithromycin |
| Start date | Nov 1, 1992 |
| Primary completion | Nov 1, 1994 |
| Completion | Nov 1, 1994 |
| First posted | Aug 31, 2001 |
| Last update posted | Jan 16, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: